REGENXBIO Inc. (RGNX) earnings
RGNX earnings moved a median of 0.00% by the close. Quarterly and annual RGNX reports and results, each read against the price at its own news timestamp. Back to the RGNX overview →
29 measured RGNX earnings events.
Where these RGNX earnings landedvs 29 measured RGNX earnings reactions
| Middle 50% of RGNX earnings reactions | -1.99% to +4.68% |
|---|---|
| Median reaction (to close) | 0.00% |
| Measured reactions | 29 |
Point-in-time · zero look-ahead
Half of the 29 RGNX earnings events with a measured close landed between -1.99% and +4.68%; 45% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q REGENXBIO Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.93% | +0.00% | |
| REGENXBIO Reports Second Quarter 2026 Financial Results and Operational Highlights | Press release | +0.93% | +0.00% | |
| REGENXBIO to Host Conference Call on August 6 to Discuss Second Quarter 2026 Financial Results and Operational Highlights | Press release | -3.05% | +3.11% | |
| Form 10-Q REGENXBIO Inc. For: Mar 31 | SEC filing · Form 10-Q | -12.13% | -22.71% | |
| REGENXBIO Reports First Quarter 2026 Financial Results and Operational Highlights | Press release | -12.13% | -22.71% | |
| Form 10-K REGENXBIO Inc. For: Dec 31 | SEC filing · Form 10-K | +1.30% | +2.25% | |
| Form 10-Q REGENXBIO Inc. For: Sep 30 | SEC filing · Form 10-Q | +3.46% | -2.02% | |
| REGENXBIO Reports Third Quarter 2025 Financial Results and Operational Highlights | Press release | +3.46% | -2.02% | |
| REGENXBIO to Host Conference Call on November 6 to Discuss Third Quarter 2025 Financial Results and Operational Highlights | Press release | -2.06% | -1.99% | |
| Form 10-Q REGENXBIO Inc. For: Jun 30 | SEC filing · Form 10-Q | +3.06% | -1.25% | |
| REGENXBIO Reports Second Quarter 2025 Financial Results and Operational Highlights | Press release | +3.06% | -1.25% | |
| REGENXBIO to Host Conference Call on August 7 to Discuss Second Quarter 2025 Financial Results and Operational Highlights | Press release | -0.80% | -1.16% | |
| Form 10-Q REGENXBIO Inc. For: Mar 31 | SEC filing · Form 10-Q | +6.78% | +2.63% | |
| REGENXBIO Reports First Quarter 2025 Financial Results and Recent Operational Highlights | Press release | +6.78% | +2.63% | |
| REGENXBIO to Host Conference Call on May 12 to Discuss First Quarter 2025 Financial Results and Recent Operational Highlights | Press release | -2.76% | +2.40% | |
| Form 10-K REGENXBIO Inc. For: Dec 31 | SEC filing · Form 10-K | +6.22% | -4.95% | |
| Form 10-Q REGENXBIO Inc. For: Sep 30 | SEC filing · Form 10-Q | +2.50% | +9.71% | |
| REGENXBIO Reports Third Quarter 2024 Financial Results and Recent Operational Updates | Press release | +2.50% | +9.71% | |
| REGENXBIO to Host Conference Call on November 6 to Discuss Third Quarter 2024 Financial Results and Recent Operational Highlights | Press release | +2.35% | -1.01% | |
| Form 10-Q REGENXBIO Inc. For: Jun 30 | SEC filing · Form 10-Q | +4.14% | +5.84% | |
| REGENXBIO Reports Second Quarter 2024 Financial Results and Recent Operational Highlights | Press release | +4.14% | +5.84% | |
| REGENXBIO to Host Conference Call on August 1 to Discuss Second Quarter 2024 Financial Results and Recent Operational Highlights | Press release | -2.78% | +5.11% | |
| Form 10-Q REGENXBIO Inc. For: Mar 31 | SEC filing · Form 10-Q | -2.33% | -5.26% | |
| REGENXBIO Reports First Quarter 2024 Financial Results and Recent Operational Highlights | Press release | -2.33% | -5.26% | |
| REGENXBIO to Host Conference Call on May 8 to Discuss First Quarter 2024 Financial Results and Recent Operational Highlights | Press release | +3.27% | +4.99% | |
| Form 10-K REGENXBIO Inc. For: Dec 31 | SEC filing · Form 10-K | +0.58% | +4.68% | |
| Form 10-Q REGENXBIO Inc. For: Sep 30 | SEC filing · Form 10-Q | -2.58% | -1.35% | |
| REGENXBIO Announces Updated Strategic Plans and Third Quarter 2023 Financial Results | Press release | -2.58% | -1.35% | |
| REGENXBIO to Host Conference Call on November 8 to Discuss Third Quarter 2023 Financial Results and Recent Operational Highlights | Press release | +0.51% | +7.01% |
Keep exploring
More RGNX: analyst actions → · SEC filings → · RGNX overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| AB Corporate Bond ETF (EYEG) | 700 | 0.00% | 44% |
| STEMLINE THERAPEUTICS (STML) | 697 | +0.08% | 51% |
| ALDER BIOPHARMACEUTICALS INC (ALDR) | 693 | -0.21% | 45% |
| DIGIRAD (DRAD) | 692 | 0.00% | 39% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.